A 2023 study also revealed that the use of GLP-1 agonists for weight loss is linked to an increased risk of developing the following conditions: The incidence of acute pancreatitis and pancreatic cancer was studied in 56,000 type 2 diabetes mellitus patients on GLP-1 medication for 1 to 5 years
Given BPC-157s short half-life of under 30 minutes, this approach may be particularly relevant for injuries under constant mechanical stress like ribs
In addition, GLP-1 can also inhibit the identity loss and dysfunction of pancreatic islets cell ( PC1/3 and PC2 are neuroendocrine specific endoproteases belonging to the subtilisin-like serine protease family
But what exactly is a GLP-1 patch, how does it work, and what should you know before considering it
eligibility and terms apply
Plants, The Wall Street Journal , February 26, 2025, The Economic Impact of the U.S